Curanex Pharmaceuticals Inc [NASDAQ: CURX] price surged by 16.38 percent to reach at $0.11.
A sum of 17431235 shares traded at recent session while its average daily volume was at 4.01M shares. Curanex Pharmaceuticals Inc shares reached a high of $1.05 and dropped to a low of $0.67 until finishing in the latest session at $0.79.
Guru’s Opinion on Curanex Pharmaceuticals Inc [CURX]:
The Price to Book ratio for the last quarter was 71.84, with the Price to Cash per share for the same quarter was set at 0.00.
CURX Stock Performance Analysis:
Curanex Pharmaceuticals Inc [CURX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -33.60.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CURX stock in for the last two-week period is set at 36.78, with the RSI for the last a single of trading hit 0.7595, and the three-weeks RSI is set at 0.8378 for Curanex Pharmaceuticals Inc [CURX]. The present Moving Average recorded at 0.8772 for the last single week of trading.
Curanex Pharmaceuticals Inc (CURX) Capital Structure & Debt Analysis
According to recent financial data for Curanex Pharmaceuticals Inc. ( CURX), the Return on Equity (ROE) stands at -85.25%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -57.89%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Curanex Pharmaceuticals Inc’s Return on Invested Capital (ROIC) is -61.16%, showcasing its effectiveness in deploying capital for earnings.
Curanex Pharmaceuticals Inc (CURX) Efficiency & Liquidity Metrics
Based on Curanex Pharmaceuticals Inc’s (CURX) latest financial statements, the Debt-to-Equity Ratio is 1.55%, indicating its reliance on debt financing relative to shareholder equity.
